final program.qxd - Parallels Plesk Panel

POSTERS PRESENTATIONS - PRESENTATIONS POSTERS
Track V: Hepatitis Viruses
• PP 5.1
• PP 5.2
• PP 5.3
• PP 5.4
• PP 5.5
• PP 5.6
• PP 5.7
• PP 5.8
• PP 5.9
Rational Design of HCV Antigens to Contend with Diversity and Optimize
T cell Reactivity
Karina Yusim, Boston, usa
Detection of HIV/HCV Co-infection Markers in Blood and Saliva
ALEXANDER OLSHANSKIY, MOSCOW, RUS
Immune Restoration Levels Under Highly Active Antiretroviral Regimen, in
Patients Co-infected with HIV and HCV
ROBERTO MANFREDI, BOLOGNA, ITA
The Impact of Hepatitis on Health-related Quality of Life and Medical
Expenditures in the United States
PATRICK SULLIVAN, DENVER, USA
Fulminant Candida albicans Peritonitis and Ascites in a HIV-HCV
Co-infected Patient, Possibly Prompted by a Prolonged Self-administration
of Nimesulide
ROBERTO MANFREDI, BOLOGNA, ITA
Extrahepatic Manifestations of HCV: an experience from endemic country
ALAA SABRY, MANSOURA, EGY
Chronic Hepatitic C-prompted Peglylated Interferon (IFN) plus Ribavirin
Therapy and Re-activated, Acute, Serious Lung Tuberculosis
ROBERTO MANFREDI, BOLOGNA, ITA
Management of Chronic Hepatitis C with Pegylated Interferon and Ribavirin
in a Prison Setting
ROBERTO MANFREDI, BOLOGNA, ITA
Chronic HBV Infection Associated with Opisthorchiasis: efficacy of antiviral
therapy
OLGA KULAGINA, KEMEROVO, RUS
Track VI: Emerging Infectious Diseases
• PP 6.1
• PP 6.2
Air Evacuation of Patients with High Infectious Disease under Biosafety
Containment
MARCO LASTILLA, ROMA, ITA
Broadly Protective Immunity against Influenza A using a Synthetic Vaccine
FRANSICO DIAZ-MITOMA, OTTAWA, CAN
“ Focusing FIRST on PEOPLE “ 28 w w w . i s h e i d . c o m